Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Multiple Maxillary Periodontal Abscesses As a Manifestation of Post-Coronavirus Disease 2019 Mucormycosis: A Case Report Publisher Pubmed



Khoshkhou H1 ; Hasheminasab M2, 7 ; Goudarzi Pour D3 ; Jamali R4, 8 ; Morshedzadeh Tehrani G6 ; Moslemi N1, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Periodontology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Orthodontics, Dugoni School of Dentistry, University of the Pacific, San Francisco, United States
  3. 3. Department of Oral & Maxillofacial Radiology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Dental Research Center, Dental Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Periodontology, School of Dentistry, Qom University of Medical Sciences, Qom, Iran
  7. 7. Department of Oral and Maxillofacial Surgery and CranioMaxillofacial Research Center, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Research Development Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Medical Case Reports Published:2023


Abstract

Background: Coronavirus disease 2019 makes patients more susceptible to superinfection of fungal disease as a consequence of immunological system impairment. Mucormycosis is a fungal infection that is rare but has a high mortality rate and mostly affects patients with poorly controlled diabetes mellitus or those receiving corticosteroids. Case presentation: Here, we present a case of post-coronavirus disease 2019 mucormycosis in a 37-year-old Persian male presenting with multiple periodontal abscess with purulent discharge and necrosis of maxillary bone (without oroantral communication). Surgical debridement following antifungal therapy was the treatment of choice. Conclusion: Early diagnosis and immediate referral are the cornerstone of comprehensive treatment. © 2023, The Author(s).
Related Docs
View other Related Docs
1. Covid-19 Associated Mucormycosis (Cam) in Kashan, Iran: Clinical Presentations, Risk Factors, Management, and Outcomes, Infectious Diseases (2024)
2. Practice Guideline on Prevention, Diagnosis, and Treatment of Rhino-Orbito-Cerebral Mucormycosis in the Covid-19 Area: A Consensus of Iranian Experts, Archives of Clinical Infectious Diseases (2022)
3. Covid-19-Associated Fungal Infections in Iran: A Systematic Review, PLoS ONE (2022)
4. Mucormycosis Infection in Patients With Covid-19: A Systematic Review, Health Science Reports (2022)
5. Iranian Patients Co-Infected With Covid-19 and Mucormycosis: The Most Common Predisposing Factor, Clinical Outcomes, Laboratory Markers and Diagnosis, and Drug Therapies, Infectious Diseases (2022)
6. Covid-19 Associated Rhino-Orbito-Cerebral Mucormycosis, Risk Factors and Outcome Predictors; a Multicentric Study, International Ophthalmology (2023)
7. Diabetes Mellitus and Other Underlying Conditions in Patients With Coronavirus Disease 2019 Associated Rhino-Orbito-Cerebral Mucormycosis: A Systematic Review and Meta-Analysis, Journal of Laryngology and Otology (2022)
8. The Double-Edged Sword of Systemic Corticosteroid Therapy in Viral Pneumonia: A Case Report and Comparative Review of Influenza-Associated Mucormycosis Versus Covid-19 Associated Mucormycosis, Mycoses (2021)
Experts (# of related papers)
View all Related Experts
Mohammadreza Salehi (10)
Sadegh Khodavaisy (10)
Other Related Docs
9. Mucormycosis in Patients With Covid-19: A Cross-Sectional Descriptive Multicentre Study From Iran, Mycoses (2021)
10. Proven Cutaneous Mucormycosis in a Covid-19 Patient: A Case Report and Literature Review, Iranian Journal of Pathology (2024)
11. Relapse of Covid-19-Associated Mucormycosis in Patients Receiving Posaconazole As Maintenance Treatment, Journal of Infection in Developing Countries (2024)
12. Distinguishing Characteristics of Covid-19-Associated Mucormycosis; a Case Series, Archives of Academic Emergency Medicine (2022)
13. Covid-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran, Mycopathologia (2023)
14. Covid-19 Associated Mucormycosis Surge: A Review on Multi-Pathway Mechanisms, Parasite Immunology (2024)
15. Challenges and Pitfalls in the Management of Rhino-Orbital Mucormycosis in Ophthalmology: A Highlighted Problem in the Covid-19 Era, Journal of Ophthalmic and Vision Research (2022)
16. Anticoagulation in the Management of Septic Cavernous Sinus Thrombosis Secondary to Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Real-World Experience, Current Journal of Neurology (2024)
17. Iranian Patients With Diabetes and Covid-19-Associated Mucormycosis: Characteristics, Manifestations, and Mortality Risk Factors, International Journal of Diabetes in Developing Countries (2024)
18. Covid-19-Associated Mucormycosis in Diabetic Patients: The Tip of an Iceberg, Iranian Journal of Public Health (2022)
19. A Case of Covid-19-Associated Mucormycosis Due to Lichtheimia Ramosa, Journal of Clinical Laboratory Analysis (2023)
20. Risk Factors of Covid-19 Associated Mucormycosis (Cam) in Iranian Patients: A Single-Center Retrospective Study, Mycopathologia (2022)
21. Ear and Face Mucormycosis; a Case Report, International Tinnitus Journal (2021)
22. Mixed Aspergillosis and Mucormycosis Infections in Patients With Covid-19: Case Series and Literature Review, Mycopathologia (2024)
23. Case Report: Covid-19-Associated Mucormycosis Co-Infection With Lomentospora Prolificans: The First Case and Review on Multiple Fungal Co-Infections During Covid-19 Pandemic, Frontiers in Medicine (2023)
24. Mucormycosis Infection in Severe Covid-19 Patient With Multiple Underlying Health Conditions, Clinical Case Reports (2021)
25. Epidemiology, Risk Factors, Species Distribution, and Antifungal Susceptibility of Candidemia Among Hospitalized Patients With Covid-19, Current Medical Mycology (2021)
26. Coronavirus Disease 2019 (Covid-19)-Associated Brain Abscesses Caused by Pseudomonas Aeruginosa and Aspergillus Fumigatus: Two Case and A Review of The Literature, Journal of Medical Case Reports (2023)
27. Case Report: Covid-19-Associated Rhinosinusitis Mucormycosis Caused by Rhizopus Arrhizus: A Rare But Potentially Fatal Infection Occurring After Treatment With Corticosteroids, American Journal of Tropical Medicine and Hygiene (2021)
28. A Rare Case of an Immunocompetent Patient With Isolated Pulmonary Mucormycosis, IDCases (2023)
29. Percentage of Th1 and Th17 Cells and Serum Level of Il-17 and Ifn-Γcytokines in Covid-19-Associated Mucormycosis, Medical Mycology (2023)
30. Fatal Necrotising Cutaneous Mucormycosis Due to Novel Saksenaea Species: A Case Study, Journal of Wound Care (2021)
31. Subglottic Mucormycosis in a Covid-19 Patient: A Rare Case Report, Oxford Medical Case Reports (2022)
32. Black Fungus and Beyond: Covid-19 Associated Infections, Clinical Imaging (2022)
33. Covid‑19‑Associated Mucormycosis: A Review of an Emergent Epidemic Fungal Infection in the Era of Covid‑19 Pandemic, Journal of Research in Medical Sciences (2022)